Complete Health Formulation 2 for Immune Metabolic and Gut Brain Support

Product Overview

AMILI Probiotics Formulation 2, designated the Complete Health formulation, represents the broadest-spectrum product in the AMILI precision probiotics range. While Formulation 1 targets immune defence specifically, Formulation 2 addresses the interconnected triad of immune regulation, metabolic efficiency, and the gut-brain axis through a six-strain probiotic consortium delivering 12 billion colony-forming units per capsule. This expanded strain diversity reflects current microbiome science indicating that multi-strain formulations produce synergistic metabolic outputs including short-chain fatty acids (SCFAs), neurotransmitter precursors, and immunomodulatory metabolites that single-strain products cannot replicate.

The formulation was developed by AMILI Pte Ltd using proprietary data from Asia's largest multi-ethnic gut microbiome reference database (AMILI BioCloud), ensuring strain selection is calibrated to the microbial ecology of individuals living in Southeast Asian environments. The inclusion of Bifidobacterium breve and Lacticaseibacillus rhamnosus alongside the core immune strains extends the formulation's functional reach to metabolic parameter modulation and gut-brain signalling via vagal nerve pathways. Delayed-release vegetarian capsules protect organism viability through gastric acid transit, maximising colonic delivery where host-microbe immunological interactions are concentrated.

Specifications

Clinical Indications and Key Applications

• Comprehensive daily wellness support for adults seeking simultaneous immune, metabolic, and cognitive health optimisation through a single formulation
• Gut-brain axis modulation for individuals experiencing stress-related digestive disturbances, mood fluctuations, or cognitive fatigue linked to gut dysbiosis
• Metabolic parameter support including healthy blood glucose regulation and lipid metabolism mediated by SCFA-producing Bifidobacterium and Lactobacillus strains
• Post-antibiotic microbiome reconstitution requiring broad-spectrum recolonisation across multiple bacterial genera
• Recommended formulation for individuals with AMILI Enhanced Gut Microbiome Test results indicating multi-domain deficiencies across immune, metabolic, and neurological biomarker categories
• Preventive gut health maintenance for healthcare professionals, shift workers, and individuals with irregular dietary patterns that compromise microbial diversity

Frequently Asked Questions

What distinguishes Formulation 2 from Formulation 1 in the AMILI range?

Formulation 1 delivers 9 billion CFU across 4 strains focused primarily on immune defence via Bifidobacterium animalis subsp. lactis. Formulation 2 expands to 12 billion CFU across 6 strains, adding Bifidobacterium breve and Lacticaseibacillus rhamnosus to address metabolic regulation and gut-brain signalling in addition to immune support. Formulation 2 is recommended for individuals whose AMILI microbiome test results indicate deficiencies across multiple functional domains, or for those seeking a single broad-spectrum formulation covering immune, metabolic, and cognitive wellness targets.

How does the gut-brain axis mechanism work in this formulation?

The gut-brain axis refers to bidirectional communication between the enteric nervous system and the central nervous system, mediated through vagal nerve afferents, neuroactive metabolites, and immune signalling molecules. Specific strains in Formulation 2, particularly Bifidobacterium longum and Lacticaseibacillus rhamnosus, produce gamma-aminobutyric acid (GABA) precursors and modulate tryptophan metabolism, which influences serotonin synthesis. Published research in the journal Frontiers in Neuroscience has demonstrated that these bacterial metabolites can influence mood regulation, stress resilience, and cognitive function through enteroendocrine and immune-mediated pathways.

Can Formulation 2 be taken concurrently with prescription medications?

Probiotic supplements are generally well-tolerated alongside most medications. However, individuals taking immunosuppressive agents, chemotherapy, or systemic corticosteroids should consult their prescribing physician before initiating probiotic supplementation, as enhanced immune activation may not be appropriate in immunocompromised states. A 2-hour separation between probiotic capsule ingestion and antibiotic dosing is recommended to minimise direct antimicrobial exposure to the probiotic organisms. The World Gastroenterology Organisation (WGO) guidelines recommend healthcare provider consultation for individuals with central venous catheters, short bowel syndrome, or severe acute pancreatitis.

What is the evidence base for multi-strain probiotic formulations versus single-strain products?

A systematic review published in Nutrients (2021) analysed 42 randomised controlled trials comparing multi-strain and single-strain probiotics, concluding that multi-strain formulations demonstrated broader functional effects across immune, metabolic, and gastrointestinal endpoints. The proposed mechanism is ecological synergy: different strains occupy complementary metabolic niches, produce diverse SCFAs (acetate, propionate, butyrate), and collectively resist pathogen colonisation more effectively than monocultures. AMILI's six-strain consortium was specifically designed to maximise this synergistic potential based on co-occurrence patterns observed in healthy Asian gut microbiome profiles.

Is this product available for institutional procurement in Singapore?

Yes. EMIS (Essential Medical International Supplies Pte Ltd) is an authorised Singapore distributor for AMILI precision probiotics. Healthcare institutions, wellness clinics, and integrative medicine practices can arrange B2B procurement with volume pricing. AMILI probiotics are classified as health supplements under the Health Sciences Authority (HSA) Singapore regulatory framework. EMIS provides Certificates of Analysis, batch traceability documentation, and cold-chain logistics support for institutional orders requiring temperature-controlled delivery.